StonvexLoading…
StonvexCore line items from PLUS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q2 2026 (Est.) Expected 2026-05-27 | Annual 2018 2018-03-31 | Annual 2017 2017-12-31 | Annual 2017 2017-09-30 | Annual 2017 2017-06-30 |
|---|---|---|---|---|---|
Revenue | $580.63M | $1.41B | $342.57M | $370.85M | $367.16M |
Operating Income | Not available | $84.24M | $16.39M | $28.83M | $20.51M |
Net Income | Not available | $55.12M | $15.58M | $17.22M | $13.42M |
EPS (Diluted) | $1.00 | $3.95 | $1.11 | $1.23 | $0.96 |
Total Assets | Not available | $755.47M | $760.51M | $734.29M | $755.18M |
Total Liabilities | Not available | $382.87M | $381.04M | $362.93M | $398.15M |
Cash & Equivalents | Not available | $118.20M | $76.11M | $60.19M | $98.24M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | 13.76M | 14.05M | 14.17M | 14.17M |